Anti-inflammatory activity and gastric lesions induced by zinc-tenoxicam

Pharmacology

Volumn 68, Issue 2, 2003, Pages 64-69

  Nascimento, Jorge Willian L ^a   Santos, Luiz Henrique ^a   Nothenberg, Michael S ^b   Coelho, Márcio M ^a   Oga, Seizi ^b   Tagliati, Carlos A ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Anti inflammatory activity; Gastric lesions; Granulomatous tissue; Oedema formation; Zinc tenoxicam complex

Indexed keywords

ACETIC ACID; ANTIINFLAMMATORY AGENT; CARRAGEENAN; TENOXICAM; ZINC; ZINC ACETATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG ACTIVITY; GRANULOMATOUS INFLAMMATION; MALE; NONHUMAN; PAW EDEMA; PRIORITY JOURNAL; RAT; STOMACH LESION; WRITHING TEST;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CARRAGEENAN; EDEMA; MALE; MICE; PEPTIC ULCER; PIROXICAM; RATS; RATS, WISTAR; ZINC ACETATE;

EID: 0037262729     PISSN: 00317012     EISSN: None     Source Type: Journal    
DOI: 10.1159/000069531     Document Type: Article

References (24)

1. Gonzalez JP, Todd PA: Tenoxicam: A preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy. Drugs 1987;34:289-310.
2. Elhakim M, Nafie M: Tenoxicam for analgesia during caesarean section. Br J Anaesth 1995; 74:643-646.
3. Curry C, Kelly AM: Intravenous tenoxicam for the treatment of renal colic. N Z Med J 1995; 108:229-230.
4. Todd PA, Clissold SP: Tenoxicam: An update of its pharmacological and therapeutic efficacy in rheumatic diseases. Drugs 1991;41:625-646.
5. Nilsen OG: Clinical pharmacokinetics of tenoxicam. Clin Pharmacokinet 1994;26:16-43.
6. Guentert TW, Heintz RC, Joly R: Overview on the pharmacokinetics of tenoxicam. Eur J Rheumatol Inflamm 1987;9:15-25.
7. Raskin JB, White RH, Jaszewski R, Korsten MA, Schebert TT, Fort JG: Misoprostol and ranitidine in the prevention of NSAID-induced ulcers: A prospective, double-blind, multicenter study. Am J Gastroenterol 1996;91:223-227.
8. Fraser PM, Doll R, Langman SM, Misiewicz JJ, Shawdon HH: Clinical trial of a new carbenoxolone analogue (BX24), zinc sulphate, and vitamin A in the treatment of gastric ulcer. Gut 1972;13:459-461.
9. Frommer DJ: The healing of gastric ulcers by zinc sulphate. Med J Aust 1975;ii:793-796.
10. Bravo L, Escolar G, Navarro C, Fontarnau R, Bulbena O: Effect of zinc acexamate on gastric lesions induced by aspirin: A morphological study. Eur J Pharmacol 1990;190:59-65.
11. Bulbena O, Escolar G, Navarro C, Bravo L, Pfeiffer CJ: Gastroprotective effect of zinc acexamate against damage induced by nonsteroidal anti-inflammatory drugs: A morphological study. Dig Dis Sci 1993;38:730-739.
12. Escolar G, Navarro C, Sendros S, Bulbena O: Effect of cold-restraint stress and zinc acexamate on gastric mucus production in intact glands. Arch Int Pharmacodyn Ther 1987;290:128-137.
13. Rodriguez de la Serna A, Diaz-Rubio M: Multicenter clinical trial of zinc acexamate in the prevention of nonsteroidal antiinflammatory drug induced gastroenteropathy. Spanish Study Group on NSAID-Induced Gastroenteropathy Prevention. J Rheumatol 1994;21:927-933.
14. Kraag GR, Gordon DG, Ménard HA, Russell AS, Kalish GH: Patient compliance with tenoxicam in family practice. Clin Ther 1994;16:58-93.
15. Tagliati CA, Kimura E, Nothemberg MS, Santos SRC, Oga S: Pharmacokinetic profile and adverse gastric effect of zinc-piroxicam in rats. Gen Pharmacol 1999;33:67-71.
16. Cini R, Giorgi G, Cinquantini A, Rossi C, Sabat M: Metal complexes of the anti-inflammatory drug piroxicam. Inorg Chem 1990;29:5197-5200.
17. Vaz ZR, Filho VC, Yunes RA, Calixto JB: Antinociceptive action of 2-(4-bromobenzoyl)-3-methyl-4,6-dimethoxy benzofuran, a novel xanthoxyline derivative, on chemical and thermal models of nociception in mice. J Pharmacol Exp Ther 1996;278:304-312.
18. Koster R, Anderson M, De Beer EJ: Acetic acid for analgesic screening. Fed Proc 1959;18:412.
19. Niemegeers CJ, Brugen W, Van Awouters F, Janssen PA: The effects of suprofen in rats with implanted cotton pellets. Arzneimittelforschung 1975;25:1524-1526.
20. Rainsford KD: A synergistic interaction between aspirin, or other non-steroidal anti-inflammatory drugs, and stress which produces severe gastric mucosal damage in rats and pigs. Agents Actions 1975;5:553-558.
21. Szelenyi I, Thiemer K: Distention ulcer as a model for testing of drugs for ulcerogenic side effects. Arch Toxicol 1978;41:99-105.
22. Esplugues JV, Bulbena O, Escolar G, Marti-Bonmati E, Esplugues J: Effects of zinc acexamate on gastric mucosal resistance factors. Eur J Pharmacol 1985;109:145-151.
23. Cho CH, Ogle CW, Dai S: Effect of zinc chloride on gastric secretion and ulcer formation in pylorus-occluded rats. Eur J Pharmacol 1976;43:337-341.
24. Pfeiffer CJ, Bulbena O, Esplugues JV, Escolar G, Navarro C, Esplugues J: Anti-ulcer and membrane-stabilizing actions of zinc acexamate. Arch Int Pharmacodyn Ther 1987;285:148-157.